Solutions
Kwelix shows a health insurer’s care team which members may need help with their medication, and what drives each score, so outreach goes where it matters first.
How it fits together
How POP by Kwelio, Kwelix and LioBox fit together for an insurer’s members.
Kwelio
Kwelio
Builds POP by Kwelio, Kwelix and LioBox, and onboards each insurer.
Onboards the insurer as a client
Health insurer
Your insurer
Offers the programme to its members and runs the care team.
Invites members with an insurer code
At home
Members
People with long-term conditions, keeping to their own medication schedule.
Sign up with the code and log each dose
Member app
POP by Kwelio
Q4 2026The Pop ritual: reminders, a dose log with photo capture confirmed against the schedule, interaction notices and Lio Points.
Each member’s medication score and whether they might need support. Never photos or daily logs.
Insurer dashboard
Kwelix
Demonstration dataA prioritised outreach queue built on KAS and KIS.
A short list of who to reach first. Your care team decides.
At home, beside the app
Dispenser
LioBox
Kwelio’s own dispenser, designed from scratch. Today’s LioBox is manual and comes with Beads by Kwelio. The next one, in development with Dubai Health Innovations, dispenses each dose on schedule and syncs with POP by Kwelio.
Insurer platform
The insurer dashboard behind POP by Kwelio. It turns members’ dose records into two scores and a short, prioritised outreach queue for your care team.
Kwelio prioritises. Your care team decides.
Kwelix is built and running on demonstration data. The first insurer deployment happens at pilot.
How consistently each member keeps to their medication schedule, from 0 to 100 over a rolling 30 days, weighted by how critical each medicine is. Built from logged doses and photo capture confirmed against the schedule, not from surveys.
The likelihood of a lapse and how much it would matter, so outreach starts with the members it would help most. Your team sets the alert threshold within published ranges.
When a member puts a plan medicine on hold, it reaches the queue for the care team to confirm. The reason appears only with the member’s consent to outreach.
Trends across your members. Members still calibrating, without enough history for a score, are left out of cohort figures.
A proven idea
When a market can see what people actually do, it stops guessing. Kwelio brings that shift to the medicines people take at home.
Lending · 1989
The FICO score turned a payment history into one number. Lenders use it to decide who qualifies, and on what terms. American Express
Car insurance · late 1990s
A small device plugged into the car, and now a phone app, records how people actually drive: miles, time of day, hard braking. Insurers can price for the risk each driver really carries, so careful drivers benefit. NAIC
Medication · now
The doses a person logs become one consistent measure, from 0 to 100 over 30 days. Their care team can see who might need support, and members earn Lio Points for keeping to their schedule. During pilots, the score is never used for cover or premiums.
Healthcare is already moving this way. In the UK, an NHS study is testing connected inhaler sensors that record each dose and share it with a child’s medical team. NIHR Leicester BRC, 2024
The science
The formulas are fixed and versioned. Each insurer sets only its own alert thresholds, within published ranges.
KAS Kwelio Adherence Score
A score from 0 to 100 over a rolling 30 days: completion weighted by how critical each medicine is, photo-assisted logging, timing, and runs of missed doses. No score until a member has 14 days and 10 scheduled doses.
KIS Kwelio Intervention Score
Combines the likelihood of a lapse with its consequence, so a care team knows whom to contact first.
AUROC 0.88 on CMS DE-SynPUF (US Medicare synthetic claims), 2.1M de-duplicated records. It shows the method works; it is not yet proven on a UAE cohort. The score weights are expert-set and will be refitted on the first real cohort.
The business case
In a US study of over 857,000 chronic patients, adherence was associated with annual medical cost savings of roughly $4,400–$5,300 per patient with comorbidities. Non-adherence is associated with up to 10% of US hospital admissions, and accounts for 33–69% of medication-related hospitalisations.
In developed countries, adherence to long-term therapy for chronic illness averages around 50%.WHO, 2003
of UAE adults live with diabetes on an age-adjusted basis — among the highest prevalence rates in the world.IDF, 2024
Data and privacy
These terms go into each pilot agreement, and members are told them in plain words.
In development
With Dubai Health Innovations, part of Dubai Health, we are developing the next LioBox and Adherence Packaging. The next LioBox is automatic: synced with POP by Kwelio, it dispenses each sachet at the scheduled dose time, for prescribed medicines as well as supplements. Members who find an app a chore, often older members, can keep to their schedule with less effort.
Neither is available yet. Today’s LioBox, designed from scratch by Kwelio, is manual and already comes with Beads by Kwelio supplement orders.
For health insurers
Book a 30-minute demo. We’ll walk you through Kwelix, the KAS and KIS scores, and how a pilot works.